About Thomas Todorow
Form D filings for Vitara Biomedical from 2020 to 2024 list Thomas Todorow as director.
Thomas Todorow first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Todorow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Todorow works with at each company, as listed on that company's latest Form D.
Vitara Biomedical, Inc. · Form D, Oct 28, 2024
IR
Ian Ratcliffe
Director
MK
Manish Kothari
Director
BL
Bernard Lyons
Interim Chief Executive Officer and director
DN
Diem Nguyen
Director
TF
Ted Fjallman
Director